UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Relationship of PCSK9 and Urinary Thromboxane Excretion to Cardiovascular Events in Patients With Atrial Fibrillation

Journal of the American College of Cardiology, 2017-09, Vol.70 (12), p.1455-1462

2017

Volltextzugriff (PDF)

Platelet activation in type 2 diabetes mellitus

Journal of thrombosis and haemostasis, 2004-08, Vol.2 (8), p.1282-1291

2004

Volltextzugriff (PDF)

Transformation of Prostaglandin D 2 to 11-Dehydro Thromboxane B 2 by Baeyer-Villiger Oxidation

Lipids, 2020-01, Vol.55 (1), p.73-78

2020

Volltextzugriff (PDF)

Twice daily dosing of aspirin improves platelet inhibition in whole blood in patients with type 2 diabetes mellitus and micro- or macrovascular complications

Thrombosis and haemostasis, 2011-09, Vol.106 (3), p.491-499

2011

Volltextzugriff (PDF)

Oxidative damage, platelet activation, and inflammation to predict mobility disability and mortality in older persons: results from the health aging and body composition study

The journals of gerontology. Series A, Biological sciences and medical sciences, 2012-06, Vol.67 (6), p.671-676

2012

Volltextzugriff (PDF)

Untargeted metabolomics reveals alterations in metabolites of lipid metabolism and immune pathways in the serum of rats after long-term oral administration of Amalaki rasayana

Molecular and cellular biochemistry, 2020-01, Vol.463 (1-2), p.147-160

2020

Volltextzugriff (PDF)

Association of cyclooxygenase-2 genetic variant with cardiovascular disease

European heart journal, 2014-09, Vol.35 (33), p.2242-2248

2014

Volltextzugriff (PDF)

Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events

Circulation (New York, N.Y.), 2002-04, Vol.105 (14), p.1650-1655

2002

Volltextzugriff (PDF)

Hydrogen sulphide pathway contributes to the enhanced human platelet aggregation in hyperhomocysteinemia

Proceedings of the National Academy of Sciences - PNAS, 2013-09, Vol.110 (39), p.15812-15817

2013

Volltextzugriff (PDF)

Urinary 11‐dehydrothromboxane B2 aspirin efficacy testing is sensitive to perioperative inflammation in pediatric solid‐organ transplant patients

Pediatric blood & cancer, 2022-02, Vol.69 (2), p.e29413-n/a

2022

Volltextzugriff (PDF)

Urinary 11-dehydro-thromboxane B2 is associated with cardiovascular events and mortality in patients with atrial fibrillation

The American heart journal, 2015-09, Vol.170 (3), p.490-497.e1

2015

Volltextzugriff (PDF)

Variable platelet response to aspirin and clopidogrel in atherothrombotic disease

Circulation (New York, N.Y.), 2007-04, Vol.115 (16), p.2196-2207

2007

Volltextzugriff (PDF)

Anti Xa oral anticoagulants inhibit in vivo platelet activation by modulating glycoprotein VI shedding

Pharmacological research, 2016-11, Vol.113 (Pt A), p.484-489

2016

Volltextzugriff (PDF)

Effects of immunosuppressive agents on the hemostatic system in normal dogs

Journal of veterinary internal medicine, 2018-07, Vol.32 (4), p.1325-1333

2018

Volltextzugriff (PDF)

High on Aspirin Platelet Reactivity in Pediatric Patients Undergoing the Fontan Procedure

Circulation (New York, N.Y.), 2016-10, Vol.134 (17), p.1303-1305

2016

Volltextzugriff (PDF)

Effects of aspirin dose escalation on platelet function and urinary thromboxane and prostacyclin levels in normal dogs

Journal of veterinary pharmacology and therapeutics, 2018-02, Vol.41 (1), p.60-67

2018

Volltextzugriff (PDF)

Biomarkers of Potential Harm Among Adult Smokers and Nonsmokers in the Total Exposure Study

Nicotine & tobacco research, 2011-03, Vol.13 (3), p.182-193

2011

Volltextzugriff (PDF)

Cyclooxygenase-1 and -2-dependent prostacyclin formation in patients with atherosclerosis

Circulation (New York, N.Y.), 2000-08, Vol.102 (8), p.840-845

2000

Volltextzugriff (PDF)

Increased platelet expression of glycoprotein IIIa following aspirin treatment in aspirin‐resistant but not aspirin‐sensitive subjects

British journal of clinical pharmacology, 2014-08, Vol.78 (2), p.320-328

2014

Volltextzugriff (PDF)

Cyclooxygenase Expression and Platelet Function in Healthy Dogs Receiving Low-Dose Aspirin

Journal of veterinary internal medicine, 2013-01, Vol.27 (1), p.141-149

2013

Volltextzugriff (PDF)

Effect of assay specificity on the association of urine 11‐dehydro thromboxane B2 determination with cardiovascular risk

Journal of thrombosis and haemostasis, 2012-12, Vol.10 (12), p.2462-2469

2012

Volltextzugriff (PDF)

d-galactose induced inflammation lipid peroxidation and platelet activation in rats

Cytokine (Philadelphia, Pa.), 2014-09, Vol.69 (1), p.150-153

2014

Volltextzugriff (PDF)

Aspirin resistance detected with aggregometry cannot be explained by cyclooxygenase activity: involvement of other signaling pathway(s) in cardiovascular events of aspirin‐treated patients

Journal of thrombosis and haemostasis, 2006-06, Vol.4 (6), p.1271-1278

2006

Volltextzugriff (PDF)

Biological assessment of aspirin efficacy on healthy individuals: Heterogeneous response or aspirin failure?

Stroke (1970), 2005-02, Vol.36 (2), p.276-280

2005

Volltextzugriff (PDF)

Age-related differences in urinary 11-dehydroxythromboxane B2 between infants, children, and adolescents: Another example of developmental hemostasis?

Pediatric blood & cancer, 2014-11, Vol.61 (11), p.2074-2076

2014

Volltextzugriff (PDF)

1 – 25 von 786

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieThrombosis Research

ThemaMiddle Aged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(661)
Mit Volltextzugriff
(564)

Publikationsform

Artikel
(786)

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(549)
Life Sciences & Biomedicine
(528)
Animals
(434)
Humans
(395)
Male
(394)
Biological And Medical Sciences
(357)
Thromboxane B2 - Analogs & Derivatives
(285)
Female
(266)
Thromboxane B2 - Urine
(249)
Medical Sciences
(246)
Thromboxane B2 - Blood
(233)
Thromboxane B2 - Metabolism
(178)
Rats
(173)
Adult
(138)
Thromboxane B2 - Biosynthesis
(127)
Biochemistry & Molecular Biology
(123)
Pharmacology. Drug Treatments
(123)
Pharmacology & Pharmacy
(118)
Fundamental And Applied Biological Sciences. Psychology
(116)
Platelet Aggregation - Drug Effects
(113)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Relationship of PCSK9 and Urinary Thromboxane Excretion to Cardiovascular Events in Patients With Atrial Fibrillation

Platelet activation in type 2 diabetes mellitus

Transformation of Prostaglandin D 2 to 11-Dehydro Thromboxane B 2 by Baeyer-Villiger Oxidation

Twice daily dosing of aspirin improves platelet inhibition in whole blood in patients with type 2 diabetes mellitus and micro- or macrovascular complications

Oxidative damage, platelet activation, and inflammation to predict mobility disability and mortality in older persons: results from the health aging and body composition study

Untargeted metabolomics reveals alterations in metabolites of lipid metabolism and immune pathways in the serum of rats after long-term oral administration of Amalaki rasayana

Association of cyclooxygenase-2 genetic variant with cardiovascular disease

Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events

Hydrogen sulphide pathway contributes to the enhanced human platelet aggregation in hyperhomocysteinemia

Urinary 11‐dehydrothromboxane B2 aspirin efficacy testing is sensitive to perioperative inflammation in pediatric solid‐organ transplant patients

Urinary 11-dehydro-thromboxane B2 is associated with cardiovascular events and mortality in patients with atrial fibrillation

Variable platelet response to aspirin and clopidogrel in atherothrombotic disease

Anti Xa oral anticoagulants inhibit in vivo platelet activation by modulating glycoprotein VI shedding

Effects of immunosuppressive agents on the hemostatic system in normal dogs

High on Aspirin Platelet Reactivity in Pediatric Patients Undergoing the Fontan Procedure

Effects of aspirin dose escalation on platelet function and urinary thromboxane and prostacyclin levels in normal dogs

Biomarkers of Potential Harm Among Adult Smokers and Nonsmokers in the Total Exposure Study

Cyclooxygenase-1 and -2-dependent prostacyclin formation in patients with atherosclerosis

Increased platelet expression of glycoprotein IIIa following aspirin treatment in aspirin‐resistant but not aspirin‐sensitive subjects

Cyclooxygenase Expression and Platelet Function in Healthy Dogs Receiving Low-Dose Aspirin

Effect of assay specificity on the association of urine 11‐dehydro thromboxane B2 determination with cardiovascular risk

d-galactose induced inflammation lipid peroxidation and platelet activation in rats

Aspirin resistance detected with aggregometry cannot be explained by cyclooxygenase activity: involvement of other signaling pathway(s) in cardiovascular events of aspirin‐treated patients

Biological assessment of aspirin efficacy on healthy individuals: Heterogeneous response or aspirin failure?

Age-related differences in urinary 11-dehydroxythromboxane B2 between infants, children, and adolescents: Another example of developmental hemostasis?

Aktive Filter

Suchergebnisse filtern